Cusatuzumab (Anti-TNFSF7 / CD27L / CD70)
Cusatuzumab (Anti-TNFSF7 / CD27L / CD70) (A2747-GRP)
Products
Description
Cusatuzumab (Anti-TNFSF7 / CD27L / CD70) is a defucosylated, humanized IgG1 monoclonal antibody directed against the extracellular domain of the human CD70 molecule with potential antineoplastic activity. Cusatuzumab has the potential for the research of Acute myeloid leukemia (AML). MW: 144.36 kD.
Specifications
| Manufacturer | Selleck Chemicals LLC |
|---|---|
| Manufacturer Cat# | A2747 |
| Target | CD markers |